Biotalys NV (BTLS)

Currency in EUR
4.98
-0.02(-0.40%)
Closed·
BTLS Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
BTLS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.975.10
52 wk Range
2.515.50
Key Statistics
Prev. Close
5
Open
5.08
Day's Range
4.97-5.1
52 wk Range
2.51-5.5
Volume
26.49K
Average Volume (3m)
44.57K
1-Year Change
75.44%
Book Value / Share
0.74
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BTLS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.65
Upside
+33.53%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Biotalys NV News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Biotalys NV Company Profile

Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and anthracnose in fruits and vegetables; BIOFUN-7 targeting leafspot disease in cowpeas and other legumes; BIOFUN-4 targeting oomycetes in fruits and vegetables; BIOFUN-8 targeting altenaria in fruits, vegetables, and specialty crops; and BioIns-2 targeting key insect pests. The company was formerly known as Agrosavfe NV and changed its name to Biotalys NV in December 2019. Biotalys NV was incorporated in 2013 and is headquartered in Gent, Belgium.

Employees
63
Market
Belgium

Compare BTLS to Peers and Sector

Metrics to compare
BTLS
Peers
Sector
Relationship
P/E Ratio
−14.4x−3.1x2.6x
PEG Ratio
−0.370.000.00
Price/Book
6.9x0.9x1.6x
Price / LTM Sales
-0.7x1.3x
Upside (Analyst Target)
31.9%47.5%17.6%
Fair Value Upside
Unlock22.7%0.7%Unlock

Analyst Ratings

1 Buy
0 Hold
1 Sell
Ratings:
2 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 6.65
(+33.53% Upside)

Earnings

Latest Release
Mar 18, 2025
EPS / Forecast
-0.20 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

BTLS Income Statement

People Also Watch

247.20
ESLX
+0.41%
22.50
STMPA
-16.60%
15.22
UMI
-0.91%
19.65
ENGIE
+0.26%
93.53
NOVN
+0.44%

FAQ

What Stock Exchange Does Biotalys NV Trade On?

Biotalys NV is listed and trades on the Brussels Stock Exchange stock exchange.

What Is the Stock Symbol for Biotalys NV?

The stock symbol for Biotalys NV is "BTLS."

What Is the Biotalys NV Market Cap?

As of today, Biotalys NV market cap is 186.60M.

What Is Biotalys NV's Earnings Per Share (TTM)?

The Biotalys NV EPS (TTM) is -0.40.

From a Technical Analysis Perspective, Is BTLS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Biotalys NV Stock Split?

Biotalys NV has split 0 times.

How Many Employees Does Biotalys NV Have?

Biotalys NV has 63 employees.

What is the current trading status of Biotalys NV (BTLS)?

As of 24 Jul 2025, Biotalys NV (BTLS) is trading at a price of 4.98, with a previous close of 5.00. The stock has fluctuated within a day range of 4.97 to 5.10, while its 52-week range spans from 2.51 to 5.50.

What Is Biotalys NV (BTLS) Price Target According to Analysts?

The average 12-month price target for Biotalys NV is EUR6.65, with a high estimate of EUR7.2 and a low estimate of EUR6.1. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +33.53% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.